Case Report
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jan 26, 2024; 12(3): 623-629
Published online Jan 26, 2024. doi: 10.12998/wjcc.v12.i3.623
Carrimycin in the treatment of acute promyelocytic leukemia combined with pulmonary tuberculosis: A case report
Fu-Yu Yang, Lei Shao, Jie Su, Zhen-Meng Zhang
Fu-Yu Yang, Lei Shao, Jie Su, Zhen-Meng Zhang, Department of Infectious Diseases, The Affiliated Central Hospital of Shandong First Medical University, Jinan 250013, Shandong Province, China
Author contributions: Yang FY and Shao L contributed to manuscript writing; Su J contributed to data curation and review; Shao L and Zhang ZM contributed to manuscript and figure editing; All authors have read and approved the final manuscript.
Informed consent statement: Written informed consent was obtained from the patient to publish this paper.
Conflict-of-interest statement: The authors declare having no conflicts of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Lei Shao, MD, PhD, Chief Physician, Doctor, Department of Infectious Diseases, The Affiliated Central Hospital of Shandong First Medical University, No. 105 Jiefang Road, Lixia District, Jinan 250013, Shandong Province, China. shaolei0328@163.com
Received: November 22, 2023
Peer-review started: November 22, 2023
First decision: December 8, 2023
Revised: December 17, 2023
Accepted: January 4, 2024
Article in press: January 4, 2024
Published online: January 26, 2024
Core Tip

Core Tip: Here, we report a case of a patient with acute promyelocytic leukemia (APL) combined with pulmonary tuberculosis (PTB). Addition of carrimycin in a patient with tuberculosis in remission thus enabling chemotherapy for leukemia. He could not tolerate the side effects of routine anti- tuberculosis drugs because of a low white blood cell count, so carrimycin was used for treatment for PTB. He achieved complete remission of APL and PTB after six months treatment. Further research is necessary to determine whether carrimycin is therapeutically useful in PTB.